<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01128647</url>
  </required_header>
  <id_info>
    <org_study_id>Protocole 59/09</org_study_id>
    <nct_id>NCT01128647</nct_id>
  </id_info>
  <brief_title>Disposal of Oral Fructose During Exercise</brief_title>
  <official_title>Disposal of Oral Fructose During Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is evidence that total carbohydrate oxidation during exercise is higher after ingestion&#xD;
      of fructose:glucose mixture than after ingestion of equimolar amounts of glucose alone. This&#xD;
      may possible contribute to improve performance, provided that the extra carbohydrate&#xD;
      oxidation induced by fructose:glucose co-ingestion occurs in skeletal muscle. The present&#xD;
      study aims at assessing the hypothesis that, during exercise, a substantial portion of oral&#xD;
      fructose is converted into lactate prior to oxidation To identify the major pathways of&#xD;
      fructose disposal, 7 healthy endurance trained male volunteers will be studied. For each&#xD;
      participant the following measurement will be performed&#xD;
&#xD;
        -  a measurement of maximal oxygen consumption (VO2 max) on an ergometric bicycle&#xD;
&#xD;
        -  a 2 hour exercise protocol with oral administration of a glucose drink. 6,6-2H2 glucose&#xD;
           (0.44 µmol/kg/min) and 13C3 lactate (2.25 µmol/kg/min) will be infused to calculate&#xD;
           glucose and lactate kinetics. Indirect calorimetry will be performed to measure total&#xD;
           carbohydrate oxidation and expired 13CO2 will be monitored to calculate whole body&#xD;
           lactate oxidation&#xD;
&#xD;
        -  a 2 hour exercise protocol with oral administration of a glucose:fructose (72 + 48 g&#xD;
           every hour) mixture. 6,6-2H2 glucose (0.44 µmol/kg/min) and 13C3 lactate (2.25&#xD;
           µmol/kg/min) will be infused to calculate glucose and lactate kinetics. Indirect&#xD;
           calorimetry will be performed to measure total carbohydrate oxidation and expired 13CO2&#xD;
           will be monitored to calculate whole body lactate oxidation&#xD;
&#xD;
        -  a 2 hour exercise protocol with oral administration of a glucose:fructose (72 + 48 g&#xD;
           every hour) mixture with fructose labelled with 13C6 fructose to evaluate exogenous&#xD;
           fructose metabolic fate and oxidation. 6,6-2H2 glucose (0.44 µmol/kg/min) will be&#xD;
           infused to calculate glucose kinetics. Fructose conversion into lactate and glucose will&#xD;
           be evaluated by monitoring the systemic appearance of plasma 13C-labelled lactate and&#xD;
           13C-labelled glucose. Total exogenous fructose oxidation will be measured by monitoring&#xD;
           13CO2 production.&#xD;
&#xD;
      Based on these measurements, semi-quantitative estimates of total fructose oxidation,&#xD;
      fructose conversion into glucose, fructose conversion into lactate, and oxidation of&#xD;
      fructose-derived lactate will be obtained&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Fructose conversion into lactate</measure>
    <time_frame>during a 2 hour-exercise at 60% VO2 max</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total exogenous fructose oxidation</measure>
    <time_frame>during a 2 hour-exercise at 60% VO2 max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fructose conversion into glucose</measure>
    <time_frame>during a 2 hour-exercise at 60% VO2 max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidation of lactate derived from fructose</measure>
    <time_frame>during a 2 hour-exercise at 60% VO2 max</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">7</enrollment>
  <condition>Carbohydrate Metabolism at Exercise</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose:glucose drink</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>glucose drink</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy, endurance trained male volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 35 years&#xD;
&#xD;
          -  males&#xD;
&#xD;
          -  good physical health&#xD;
&#xD;
          -  weekly cycling training sessions (&gt; 3 sessions/week)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diabetes or glucose intolerance&#xD;
&#xD;
          -  past history of heart disease&#xD;
&#xD;
          -  alcohol intake &gt; 30 g/day&#xD;
&#xD;
          -  smokers&#xD;
&#xD;
          -  drug consumption&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>May 21, 2010</study_first_submitted>
  <study_first_submitted_qc>May 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2010</study_first_posted>
  <last_update_submitted>February 12, 2013</last_update_submitted>
  <last_update_submitted_qc>February 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor of Physiology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

